Literature DB >> 30291022

Long-Term Cardiovascular Morbidity in Children Born Following Fertility Treatment.

Sivan Reut Shiloh1, Eyal Sheiner1, Tamar Wainstock2, Asnat Walfisch1, Idit Segal3, Daniella Landau4, Avi Harlev5.   

Abstract

OBJECTIVE: To determine the risk of long-term cardiovascular disease (CVD) among children born following in vitro fertilization (IVF) and compared with spontaneous pregnancies. STUDY
DESIGN: A population-based cohort study including all singleton deliveries occurring between 1991and 2014 at a tertiary medical center was performed. Hospitalizations up to the age of 18 years involving CVD were evaluated in children delivered following IVF, ovulation induction, and spontaneous pregnancies. CVD included valvular disorders, hypertension, arrhythmias, rheumatic disease, cardiomyopathy, ischemic heart disease, and heart failure. Kaplan-Meier survival curves were used to compare cumulative morbidity incidence, and a Cox regression model controlled for confounders.
RESULTS: During the study period, 242 187 singleton deliveries met the inclusion criteria; 1.1% following IVF (n = 2603), and 0.7% following ovulation induction (n = 1721). Hospitalizations up to the age of 18 years involving CVD (n = 1503) were comparable in children delivered following IVF (0.6%), ovulation induction (0.7%), and spontaneous pregnancies (0.6%; P = .884). No significant difference in the cumulative incidence of CVD was noted between the groups (log rank P = .781). Controlling for maternal age, gestational age, birthweight, maternal diabetes, and hypertensive disorders in pregnancy, fertility treatment was not noted as a risk factor for long-term pediatric CVD (IVF adjusted hazard ratio 1.05, 95% CI 0.63-1.74, P = .86; ovulation induction adjusted hazard ratio 0.97, CI 95% 0.55-1.71, P = .92).
CONCLUSIONS: Singletons conceived via fertility treatments do not appear to be at an increased risk of long-term pediatric CVD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IVF offspring's health outcome; assisted reproductive technology; long-term consequences; pediatric cardio-vascular morbidity

Mesh:

Year:  2018        PMID: 30291022     DOI: 10.1016/j.jpeds.2018.08.070

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Assessment of Cardiovascular Health of Children Ages 6 to 10 Years Conceived by Assisted Reproductive Technology.

Authors:  Linlin Cui; Min Zhao; Zhirong Zhang; Wei Zhou; Jianan Lv; Jingmei Hu; Jinlong Ma; Mei Fang; Lili Yang; Costan G Magnussen; Bo Xi; Zi-Jiang Chen
Journal:  JAMA Netw Open       Date:  2021-11-01

2.  Development of the Diabetic Kidney Disease Mouse Model Culturing Embryos in α-Minimum Essential Medium In Vitro, and Feeding Barley Diet Attenuated the Pathology.

Authors:  Shiori Ishiyama; Mayu Kimura; Takao Nakagawa; Yuka Fujimoto; Kohei Uchimura; Satoshi Kishigami; Kazuki Mochizuki
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-02       Impact factor: 5.555

3.  Comparison of the cardiometabolic profiles of adolescents conceived through ART with those of a non-ART cohort.

Authors:  L A Wijs; D A Doherty; J A Keelan; P Burton; J L Yovich; L Beilin; T A Mori; R C Huang; L A Adams; J K Olynyk; O T Ayonrinde; B Penova-Veselinovic; R J Hart
Journal:  Hum Reprod       Date:  2022-07-30       Impact factor: 6.353

4.  Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses.

Authors:  Hui Ju Chih; Flavia T S Elias; Laura Gaudet; Maria P Velez
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-28       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.